[1] |
Lovestone S, Boada M, Dubois B, et al.A phase II trial of tideglusib in Alzheimer's disease[J].J Alzheimers Dis, 2015, 45(1):75-88
|
[2] |
del Ser T, Steinwachs KC, Gertz HJ, et al.Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study[J].J Alzheimers Dis, 2013, 33(1):205-215
|
[3] |
Neves VC, Babb R, Chandrasekaran D, et al.Promotion of natural tooth repair by small molecule GSK3 antagonists[J].Sci Rep, 2017, 7:39654-
|
[4] |
Baudry A, Uzunoglu E, Schneider B, et al.From pulpal stem cells to tooth repair: an emerging field for dental tissue engineering[J].Evid-Based Endod, 2016, 1(1):2-
|
[5] |
裴喜燕, 孙凤.自体牙本质颗粒在牙周和种植领域骨再生手术中的应用[J].牙体牙髓牙周病学杂志, 2018, 28(10):51-54
|
[6] |
Elgali I, Omar O, Dahlin C, et al.Guided bone regeneration: materials and biological mechanisms revisited[J].Eur J Oral Sci, 2017, 125(5):315-337
|
[7] |
Wessing B, Lettner S, Zechner W.Guided Bone Regeneration with Collagen Membranes and Particulate Graft Materials: A Systematic Review and Meta-Analysis[J].Int J Oral Maxillofac Implants, 2018, 33(1):87-100
|
[8] |
Noelken R, Moergel M, Kunkel M, et al.Immediate and flapless implant insertion and provisionalization using autogenous bone grafts in the esthetic zone: 5-year results[J].Clin Oral Implants Res, 2018, 29(3):320-327
|
[9] |
Chiapasco M, Zaniboni M, Boisco M.Augmentation procedures for the rehabilitation of deficient edentulous ridges with oral implants[J].Clin Oral Implants Res, 2010, 17(S2):136-159
|
[10] |
Bernstein S, Cooke J, Fotek P, et al.Vertical bone augmentation: where are we now?[J].Implant Dent, 2006, 15(3):219-228
|
[11] |
AlKudmani H, Al Jasser R, Andreana S.Is Bone Graft or Guided Bone Regeneration Needed When Placing Immediate Dental Implants? A Systematic Review[J].Implant Dent, 2017, 26(6):936-944
|
[12] |
Begam H, Nandi SK, Kundu B, et al.Strategies for delivering bone morphogenetic protein for bone healing[J].Mater Sci Eng C Mater Biol Appl, 2017, 70(Pt 1):856-869
|
[13] |
Xu L, Zhang W, Lv K, et al.Peri-Implant Bone Regeneration Using rhPDGF-BB, BMSCs, and β-TCP in a Canine Model[J].Clin Implant Dent Relat Res, 2016, 18(2):241-252
|
[14] |
Schorn L, Sproll C, Ommerborn M, et al.Vertical bone regeneration using rhBMP-2 and VEGF[J].Head Face Med, 2017, 13(1):11-
|
[15] |
Poon B, Kha T, Tran S, et al.Bone morphogenetic protein-2 and bone therapy: successes and pitfalls[J].J Pharm Pharmacol, 2016, 68(2):139-147
|
[16] |
Park HC, Kim SG, Oh JS, et al.Early Bone Formation at a Femur Defect Using CGF and PRF Grafts in Adult Dogs[J].Implant Dent, 2016, 25(3):387-393
|
[17] |
del Ser T, Steinwachs KC, Gertz HJ, et al.Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study[J].J Alzheimers Dis, 2013, 33(1):205-215
|
[18] |
Armagan G, Keser A, Atalay?n ?, et al.Tideglusib protects neural stem cells against NMDA receptor overactivation[J].Pharmacol Rep, 2015, 67(5):823-831
|
[19] |
Tolosa E, Litvan I, H?glinger GU, et al.A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy[J].Mov Disord, 2014, 29(4):470-478
|
[20] |
Duan P, Bonewald LF.The role of the wnt/β-catenin signaling pathway in formation and maintenance of bone and teeth[J].Int J Biochem Cell Biol, 2016, 77(Pt A):23-29
|
[21] |
Takashima K, Matsushima M, Hashimoto K, et al.Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury[J].Respir Res, 2014, 15:150-
|
[22] |
Yao Q, Yu C, Zhang X, et al.Wnt/β-catenin signaling in osteoblasts regulates global energy metabolism[J].Bone, 2017, 97:175-183
|
[23] |
Ren Q, Cai M, Zhang K, et al.Effects of bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor (VEGF) release from polylactide-poly (ethylene glycol)-polylactide (PELA) microcapsule-based scaffolds on bone[J].Braz J Med Biol Res, 2017, 51(2):e6520-
|